HEPATOSIT is a routine scientific symposium that focuses on refreshing knowledge in the hepatobiliary field. HEPATOSIT regularly presents discussions with expert speakers who have extensive experience in handling various cases in the hepatopancreatobiliary field. The main objective of HEPATOSIT is to update knowledge, enrich insights, and facilitate collaboration among healthcare professionals in the effort to improve the management of liver diseases and other related conditions. HEPATOSIT brings expert speakers who provide the latest data and share real-life experiences to encourage the development of new breakthroughs in patient management.

During the COVID-19 pandemic era, HEPATOSIT has been conducted virtually in 2021 and 2022. However, we are delighted to announce that in 2023, HEPATOSIT plans to hold an in-person symposium on November 25 - 26, 2023. We are optimistic that conducting the event in person will open up broader opportunities for personal interaction, knowledge sharing, and strengthening collaborative networks among participants.

We invite all professionals, academics, and healthcare practitioners who are interested and committed to addressing challenges in the hepatobiliary field to join the HEPATOSIT 2023 event. Together, let's enhance our understanding of liver diseases and find innovative solutions to provide the best management for patients.